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Studies of adult BALB/c mice given total lymphoid irradiation (TLI; 3,400 rad) 1 
have shown that both heterologous proteins and allogeneic bone marrow (BM) cells 
injected into irradiated mice evoke a state of tolerance rather than immunity (1). The 
ease  of induction  of tolerance  to  protein  antigens  appears  to  be  related  to  the 
development of a  population of T  cells that can nonspecifically suppress the in vivo 
adoptive antibody response to the dinitrophenyl (DNP) hapten coupled to heterolo- 
gous proteins such as bovine serum albumin  (BSA) and bovine gammaglobulin  (2). 
Similarly, the initial lack of responsiveness to allogeneic BM cells in TLI-treated mice 
is  related  to  the  presence  of T  cells  that  can  nonspecifically suppress  the  mixed 
leukocyte reaction (MLR) in vitro and graft-vs.-host disease in vivo (3). 
Our recent work demonstrated the presence of a  population of spleen and lymph 
node  cells  bearing  the  thymus-leukemia  (TL)  surface  antigen  after TLI  (1). ~ The 
object  of the  present  work was  to  determine whether these  TL  + cells  are  able  to 
suppress  the  in  vivo  adoptive  antibody  response  to  DNP-BSA,  and  the  in  vitro 
proliferative response to allogeneic stimulator cells (MLR). The results suggest that 
two  subpopulations  of suppressor  T  cells  are  present  in  TLI-treated mice:  a  TL  + 
subpopulation that mediates the suppression of the adoptive antibody response, and 
a  TL- subpopulation that mediates the suppression of the MLR. 
Materials and Methods 
Animals.  BALB/c  (H-2  d)  and  C57BL/Ka  (H-2  b)  mice were  obtained from the specific 
pathogen-free colony of Dr. Robert Kallman, Department of Radiology, Stanford University 
Medical School. Animals were housed in conventional animal rooms during administration of 
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1 Abbreviations used in this paper: ABC, antigen-binding capacity; BM, bone marrow; BSA, bovine serum 
albumin; CFA, complete Freund's adjuvant; DNP, dinitrophenyl; Iso-MEM, modified minimal essential 
medium;  MLR,  mixed  leukocyte  reaction;  NMS,  normal  mouse  serum;  SRBC,  sheep  erythrocytes; 
[aH]Tdr, tritiated thymidine; TL, thymus-leukemia; TLI, total lymphoid irradiation; WBI, whole body 
irradiation. 
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irradiation. Tetracycline (0.5/.tg/ml) was added to the drinking water during TLI and for 1 wk 
after completion of irradiation. 
Radiotherapy.  TLI  (3,400  rad)  or  WBI  (500-550  tad)  was  administered  to  4-6-too-old 
BALB/c  mice  as  described  previously  (3). TLI was  given to  ports  including the  cervical, 
axillary, mediastinal, para-aortic, and  inguinal lymph nodes, as  well  as  to  the  spleen and 
thymus (3). 17 fractions of 200 rad each were administered 5 d/wk during a period of 3-4 wk. 
Preparation of Cells.  Spleen cell suspensions  were prepared by gently pressing spleen fragments 
through a nylon fiber mesh (Tetko, Inc., Elmsford, N. Y.) into cold modified minimal essential 
medium (Iso-MEM; Grand Island Biological Co., Grand Island, N. Y.), as described before (3). 
Thymectomy.  Thymectomy was performed on 2-3-mo-old BALB/c male mice using ether or 
sodium pentobarbital for anesthesia. The incision of the neck was closed with surgical clips. At 
7-8 mo of age, half the mice were given TLI (total dose 3,400 rad), and the remainder served 
as thymectomized, nonirradiated controls. Each animal was carefully checked for the presence 
of residual thymic tissue in the mediastinum at the time of killing, and individual mice were 
eliminated from the study if thymectomy was incomplete. 
Preparation of Antigens.  BSA (Cohn fraction V; Sigma Chemical Co., St.  Louis, Mo.)  was 
dissolved in saline at a final concentration of 20 mg/ml before mixing with complete Freund's 
adjuvant (CFA).  BSA was  dinitrophenylated using a  modification of the procedure of Eisen 
(4). Readings of the absorbence of the conjugated protein at 280 and 360 nm yielded a value 
of 8.5 mg protein/ml and 10 DNP groups per molecule of BSA. 
Immuhization Piocedures.  Donors of carrier (BSA)-primed T  cells were  immunized 8-12 wk 
before cell transfer with 500 ~g BSA, by an intraperitoneal injection of an emulsion of equal 
volumes of BSA in saline and CFA (Difco  Laboratories, Detroit,  Mich).  Donors of hapten 
(DNP)-primed B cells were immunized with 500 p.g DNP-BSA in CFA as described above. 
Antisera.  Anti-Thy-l.2 antiserum was obtained by multiple immunizations  of AKR/J mice 
with C3H/Km thymoc~tes, according to the method of Reif and Allen (5). The first immuni- 
zation i'ncluded 1 X 10  Bordetella  pertussis organisms (Public Health Dept., Commonwealth of 
Massachusetts)  as  adjuvant. Anti-TL antiserum [(C57  X  A/Tlab)F1 anti-ASL1]  was  kindly 
provided by Dr. E. S. Vitetta, University of Texas, Dallas. 
Preparation of Purified T Cells.  Cell suspensions of mesenteric lymph nodes taken from BSA- 
primed donors -8 wk after immunization  were applied to columns of nylon wool (LP-1 Leuko- 
Pak filter; Fenwal Laboratories, Morton Grove, Ill.), as described by Julius et al.  (6). Nylon 
Wool was washed before use by boiling in distilled water, and dried in an oven. Approximately 
3.6 g of nylon wool was gently picked free of clumps, and the wool was packed to the 50-ml 
mark in 60-ml syringes.  The column was wet with Iso-MEM containing 5% heat-inactivated 
fetal calf serum  (Grand Island Biological Co.), and allowed to equilibrate for  1 h  at  37°C. 
Approximately 65 X 106 cells in 1.5 ml were loaded in each column, and the columns were re- 
incubated at 37°C for 45 rain. Nonadherent cells were removed from the column with an excess 
(120  ml) of medium by gently flushing the column. Direct cytotoxicity of the effluent cells 
using the anti-Thy-l.2 alloantiserum and complement resulted in lysis of 85% or more of the 
nonadherent population. 
Preparation ofDNP-primed B Cells.  T cells were depleted from spleen cell suspensions prepared 
from DNP-BSA-primed donors by a  two-stage in vitro cytotoxicity procedure. Cells at  10 X 
106/ml were incubated with anti-Thy-l.2 serum (final dilution, 1:5 in Iso-MEM) for 45 min at 
4°C. The suspension was spun down and the cells were  resuspended in an equal volume of 
agarose-absorbed rabbit serum, diluted 1:12 (complement source).  The reaction mixture was 
incubated for  45  min at  37°C.  The  remaining cells  were  spun  down,  washed  twice,  and 
resuspended in Iso-MEM before injection into adoptive hosts.  Approximately 40-55% of the 
spleen cells were lysed by this procedure. 
Treatment of Cells from TLl-treated Donors with Antisera and Complement.  Spleen cell suspensions 
were prepared from mice after the completion of TLI. Cells (10 X 106/ml) were incubated for 
45 min at 4°C with anti-Thy-1.2 or anti-TL antiserum (final dilution of anti-Thy-1.2 antiserum, 
1:5; final dilution of anti-TL antiserum, 1:15). Cells were collected by centrifugation, resus- 
pended in an equo.! volume of a  1:12 dilution of agarose-absorbed rabbit complement, and 
incubated for 45 min at 37°C. Residual spleen cells were spun down and resuspended in Iso- 
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cells to be used in the MLR assay, complement treatment was repeated twice to ensure complete 
lysis of all target cells. 
Cell Transfer System.  3-4-too-old BALB/c mice were given 500 rad WBI. 1 d later, they were 
injected intravenously with limiting numbers (5 ×  106) of BSA-primed, nylon wool-purified T 
cells and an excess  (5  ×  106) of DNP-primed, anti-Thy-l.2-treated B cells. The B cells were 
determined to be in excess in a series of experiments in which animals reconstituted with 10 × 
106 T cells and graded numbers of purified B cells showed identical, maximal levels of the anti- 
DNP antibody response with cell doses between 5 ×  106 and 25 ×  106 B cells. The dose of 5 X 
106 BSA-primed T cells was determined to be on the linear portion of the dose response curve 
in a similar experiment (data not shown). Adoptive hosts were challenged with 200/~g  DNP- 
BSA  in saline intraperitoneally 1 d  after cell  transfer.  The animals had  a  combination of 
antibiotics consisting of 10 mg/ml polymyxin B (Sigma Chemical Co.) and 50 mg/ml neomycin 
sulfate (Pharma-Tek, Inc., Huntington, N. Y.) added to their drinking water from 1 wk before 
irradiation to 2 wk after cell transfer. The recipients were housed in conventional  animal rooms 
with food and water ad libitum. 
Antibody Titration.  Mice were bled from the retro-orbital plexus at  weekly intervals after 
antigenic challenge. The serum was  separated  by centrifugation and stored at  -20°C. The 
anti-DNP content of the sera was calculated in terms of antigen-binding  capacity (ABC), using 
[3H]-DNP-lysine (New England Nuclear Corp., Boston, Mass.)  as the ligand in a modification 
of the Farr assay (7). Each serum sample was assayed in triplicate. The mean ABC determination 
from groups of four animals was calculated as the mean of individual serum ABC within that 
group. 
Assay  for Suppression of the Adoptive Antibody Response.  In all experiments designed to determine 
the suppressor cell activity of spleen cells from TLI-treated donors, adoptive hosts received 5 
×  10  ~ DNP-primed B cells, 5 ×  106 BSA-primed T cells, and 25 ×  10  ~ cells from donors given 
TLI.  Recipients were  challenged with  DNP-BSA,  and serum antibodies were  measured as 
described above. 
MLR.  Responder (1  ×  10  ~) and stimulator (1  ×  106) cells were cultured in a final volume 
of 0.2 ml/well, using flat-bottomed microculture plates (3596; Costar, Data Packaging, Cam- 
bridge,  Mass.).  The cells  were  incubated in  RPMI-1640 medium supplemented with  10% 
human  AB  serum  (batch  A481917),  2  mM  glutamine,  100  U/ml  penicillin,  100  /~g/ml 
streptomycin, and 10 mM Hepes buffer (all from Grand Island Biological  Co.).  Cultures were 
incubated for 96 h at 37°C in anatmosphere of 5% CO2 in air. Stimulator cells were treated 
with 3,400 rad from a 137Cesource (Mark 1 model 25 irradiator, J. L. Shepherd and Associates, 
Glendale, Calif.) just before culture. 
DNA synthesis was assayed by the addition of 1.0 ~Ci tritiated thymidine ([3H]TdR, sp ac 
6.7  Ci/mM;  New  England Nuclear  Corp.)  to  each  culture  during the  final  18  h  of the 
incubation period. Cultures were harvested onto glass fiber filter paper (Whatman, Inc., Clifton, 
N. J.)  by means of an automated sample harvester (Bio-Plastics,  Redwood City, Calif.). The 
filters were washed  with saline, dried, and placed  into a  scintillation cocktail composed of 
spectrafluor (Amersham Corp., Arlington Heights, Ill.) and toluene. Isotope incorporation was 
measured in a liquid scintillation counter (Beckman Instruments, Inc., Fullerton, Calif.). 
MLR-Suppressor Assay.  Culture conditions were as described for the MLR except that  1 × 
10  6 responder, stimulator, and putative suppressor cells were incubated in a final volume of 0.3 
ml/well. Stimulator and putative suppressor cells were treated in vitro with 3,400 and  1,500 
rad, respectively, before assay. Data shown for all MLR cultures are the mean cpm and the SE 
of triplicate cultures. The stimulation index was calculated as the ratio of cpm from cultures 
containing  allogeneic responder and stimulator cells to cpm from cultures containing  syngeneic 
responder and stimulator cells. The following formula was used to calculate suppression: 
percent suppression =  1 -  cpm withcpmPUtatiVewith  controlcellsSuppress°r cells ×  100. 
Results 
Development of Suppressor Cells of the Adoptive Anti-DNP Response after TLL  25 ×  l0  G 
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transferred to  adoptive hosts  along with  BSA-primed T  ceils  (5  ×  106) and DNP- 
primed B cells (5 ×  106). In both cases, putative suppressor cells were obtained -  1 mo 
after irradiation. Recipient mice were challenged intraperitoneally  with DNP-BSA in 
saline, and anti-DNP serum antibodies were determined. Table I  shows that spleen 
cells  from  TLI-treated  donors,  but  not  from  donors  treated  with  sublethal  WBI, 
suppressed  the  adoptive anti-DNP response on days  14  and  21  by 99  and 92%  as 
compared  with  that  observed  with  25  ×  106  cells  from  normal  (nonirradiated) 
BALB/c mice. Suppression of the response was evident at all times measured up to 35 
d  after challenge (data not shown). In addition, the level of suppression in different 
experiments varied somewhat. The mean percent suppression from five experiments 
was  89%  at  day  14  and 86%  at  day  21  after  challenge. The  injection of 25  ×  106 
normal cells appeared to have no substantial effect on the magnitude of the response 
exhibited by primed T  and B cells alone. The responses of adoptive hosts receiving 25 
×  106 cells from normal or WBI-treated donors were similar (Table I). 
Persistence of Suppressor Cells of the Adoptive Anti-DNP Responses after TLI.  To deter- 
mine the kinetics of suppressor cell activity after completion of TLI, spleen cells were 
obtained from mice at various times after radiotherapy. Cells obtained from mice at 
similar times after a single dose of WBI served as controls. As seen in Table II, transfer 
of 25  ×  106  spleen cells obtained from  TLI-treated donors  1 mo  after  irradiation 
resulted in suppression of the adoptive anti-DNP response by >90% as compared with 
transfer of a similar number of cells obtained from WBI donors at the same time after 
irradiation. Similar results were obtained at 3 and 5 mo after TLI (Table II). Although 
cells taken from TLI-treated donors within 1 mo after irradiation appeared to show 
greater suppression than spleen cells taken at later times after TLI (~90% suppression 
vs. ~80% suppression, Table II), variability in the level of suppression between similar 
experimental groups could account for these differences. 
Surface Markers of TLI-induced Suppressor Cells of the Adoptive Anti-DNP Response.  The 
surface  markers  of  the  suppressor  cells  of  the  adoptive  anti-DNP  response  were 
examined by incubating the spleen cells from TLI donors in vitro with anti-Thy-1.2 
or anti-TL antisera and complement before transfer to adoptive hosts.  In each case, 
TABLE  I 
Suppression of the Adoptive Anti-DNP Response by Spleen Cells  fiom TLl-treated Mice 
BSA-  DNP-  Putative  ABC§ 
primed T  primed B  suppressor  Treatment of donor of sup- 
cells*  cells  cells  pressor cells:[:  Day 14  Day 21 
gg DNP/ml serum 
+  +  -  0.14  + ,02  0.14 + .02 
+  +  +  None (normal)  0.13  ± ,03  0.12 :tz .01 
+  +  +  WBI (550 rad)  0.12  ± .01  0.22 ± .02 
+  +  +  TLI (3,400 tad)  0.001 "4- .001  0.01 ± .01 
+  -  -  <o.oo 1  <o.oo 1 
--  +  --  <0.001  <0.001 
* Sublethally irradiated (500 rad) mice were injected with 5 X 106 BSA-primed  T cells and 5 X 106 DNP- 
primed B cells. 
:~ Adoptive hosts also received 25 ×  106 cells taken from TLI-treated or WBI donors 30 d after completion 
of irradiation. Adoptive hosts were challenged with DNP-BSA 1 d after cell transfer. 
§ ABC of serum was measured at days 14 and 2 l after antigenic challenge. The mean of four mice ± SD 
is shown for each group. One of five experiments is shown. DONNA  P.  KING  AND  SAMUEL  STROBER  17 
TABLE II 
Persistence of Suppressor Cells of the Adoptive  Anti-DNP Response after Completion of TLI 
BSA-  DNP-  Treatment of donor of  Mo after  primed T  primed B 
cells*  cells  suppressor eell:~  irradiation 
ABC§ 
Day 14  Day 21 
I~g DNP/ml serum 
+  +  WBI (550 rad)  1  0.12 ±  .01  0.22 ±  .02 
+  +  TLI (3,400 rad)  1  0.001  ~  .001  0.01 ±  .01 
+  +  WBI (550 rad)  3  0.07 ±  .01  0.10 ±  .02 
+  +  TLI (3,400 rad)  3  0.01 ±  .01  0.01 ±  .01 
+  +  WBI (550 rad)  5  0.12 ±  .02  0.25:1:.03 
+  +  TLI (3,400 rad)  5  0.03 ±  .03  0.02 ±  .02 
* Sublethally irradiated mice received 5 ×  106 primed T  cells and 5 ×  106 primed B cells. Adoptive hosts 
were challenged with DNP-BSA 1 d after cell transfer. 
:[: Adoptive hosts received 25 ×  106 cells taken from TLI-treated or WBLtreated donors at various times 
after completion of irradiation. 
§ ABC of serum was measured at days 14 and 21 after antigenic challenge. The mean response of four mice 
:t: SD is shown. One of two experiments is shown in each case. 
TABLE  III 
Nature of the Suppressor Cell Found in TLI-treated Mice 
BSA-  DNP-  Treatment of donor of  Treatment of  ABC[[ 
primed T  primed B  suppressor cells:~  suppressor cells§ 
cells*  cells  Day 14  Day 21 
I~g DNP/ml serum 
+  +  WBI (550 rad)  0.16 +  .01  0.16 ±  .01 
+  +  TLI (3,400 rad)  0.03 :k .01  0.06 +  .01 
+  +  TLI  NMS  0.03 +  .02  0.06 ±  .02 
+  +  TLI  Anti-Thy-  1.2  0.08 ±  .02  0.11 ±  .03 
+  +  TLI  Anti-TL  0.15 ±  .02  0.20 ±  .01 
* Sublethally irradiated mice received 5 ×  10  6 primed T  cells and 5 ×  106 primed B cells. Adoptive hosts 
were challenged with DNP-BSA 1 d after cell transfer. 
* Adoptive host received 25 ×  104 spleen cells from mice given TLI or WBI. Spleens were obtained ~90 d 
after irradiation. 
§ Spleen  cells  were  treated  in  vitro  with  antisera and  complement  before  cell  transfer  (described  in 
Materials and Methods). 
[I ABC of serum was measured 14 and 21 d after antigenic challenge. Mean of response of four mice ±  SD 
is shown. One of four experiments is shown. 
the antiserum  was used at a  concentration  known  to be on the plateau  portion of the 
dilution  curve.  Control  responses  were  those  of adoptive  hosts  receiving  25  ×  106 
untreated  cells from WBI-treated  animals or 25  ×  106 cells from TLI-treated  animals 
treated with normal  mouse serum  (NMS)  and complement  before transfer. Cells were 
obtained  1 mo after either TLI  or WBI. 
Table  III shows that  both  anti-Thy-l.2  and  anti-TL  treatment  of spleen cells from 
TLI-treated  donors  markedly  reduced  their  suppressive  activity.  In  the  case  of 
treatment  with the anti-TL  serum, suppression was completely eliminated  (Table III). 
The  same pattern  was seen in four out of four experiments  (data not shown).  Spleen 
cells  from  TLI-treated  mice  that  were  treated  with  NMS  and  complement  before 
transfer  still  exhibited  potent  suppressive  activity  (Table  III).  These  results  suggest 
that the suppressor cells of the adoptive  anti-DNP  response are a  population  of T  cells 
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Effect  of Thymectomy  on Anti-DNP Suppressor  Cell Activity.  Our recent work  .)  shows 
that  adult thymectomy before TLI will prevent the appearance of cells bearing the 
TL surface  antigens (TL  + cells)  in the  peripheral tissues of irradiated mice.  It was 
therefore of interest to determine the effect of thymectomy on the generation of cells 
capable of suppressing the  adoptive anti-DNP response.  Adult  BALB/c mice were 
thymectomized as  described  in Materials and  Methods.  5-6 mo  after surgery, one 
half of the thymectomized group was given TLI (total dose, 3,400 rad). The remainder 
of the mice served as thymectomized, nonirradiated control animals. Cell suspensions 
were prepared from spleens obtained from mice given a single dose of WBI, from non- 
irradiated, thymectomized mice, and from TLI-treated mice both with and without 
thymectomy before irradiation. Cells were obtained from all irradiated donors within 
3 mo after completion of irradiation and transferred with primed T  and B cells into 
adoptive hosts. 
As seen before, spleen cells from TLI-treated animals markedly reduced the anti- 
DNP  response of adoptive hosts,  as  compared with  cells from WBI-treated control 
mice (Table IV). However, thymectomy of donor mice before administration of TLI 
completely eliminated the suppressor activity of the spleen cells  (Table IV).  Spleen 
cells  from  thymectomized, nonirradiated mice  did  not  suppress  the  adoptive  anti- 
DNP response (Table IV). 
Surface  Markers  of TLI-induced Suppressor  Cells  of the  MLR.  It  has  previously been 
established that spleen cells obtained from mice within 40 d of completion of TLI will 
markedly suppress the MLR  of BALB/c responders against C57BL/Ka stimulators 
and vice versa (3).  MLR  suppressor activity can be eliminated by treatment of the 
spleen  cells  with  anti-Thy-l.2  antibodies  and  complement  before  assay  (3).  To 
determine whether the MLR  suppressor T  cells are also TL  +, spleen cells obtained 
from  mice  within  15  d  of completion of TLI  were  treated  in  vitro  with  anti-TL 
antiserum and complement before assay in the MLR.  In each experiment, separate 
aliquots of the spleen cells from irradiated mice were treated either with NMS from 
C57BL/Ka mice or with anti-Thy-l.2 serum and complement to  serve as  negative 
TABLE  IV 
Effect of Thsrnectom  5 on Suppression of the Adoptive Anti-DNP Response b  5 Spleen Cells  from TLl-treated 
Mice 
BSA-  DNP- 
primed T  primed B 
cells*  cells 
Treatment of donor of suppressor cells~  ABC§ 
Thymec-  Irradiation  Day 14  Day 21 
tomy 
gg DNP/ml serum 
+  +  -  WBI (550 rad)  0.19 ~ .01  0.18 + .01 
+  +  --  TLI (3,400 rad)  0.004 ± .003  0.01 +__ .01 
+  +  +  --  0.14 + .03  0.12 ± .01 
+  +  +  TLI (3,400 rad)  0.26 +  01  0.23 + .01 
* Sublethally irradiated mice received 5 Y 106 primed T cells and 5 x  10  n primed B cells. Adoptive hosts 
were challenged with DNP-BSA 1 d after cell transfer. 
:~ Adoptive hosts received 25 X 10  6 spleen cells from one of the following:  normal BALB/c mice, mice given 
WBI, or mice given  TLI, with or without prior thymectomy (see text for details). 
§ ABC of serum was measured 14 and 21 d after antigenic challenge. Mean of response of four mice + SD 
is shown. One of two experiments is shown. DONNA  P.  KING AND  SAMUEL STROBER  19 
and positive controls, respectively. All cells received 1,500 rad in vitro before addition 
to the MLR. 
As shown  in  Table  V,  treatment  of the spleen  cells from  TLI-treated mice with 
anti-Thy-l.2  antibodies  and  complement  substantially  reduced  their  suppressive 
activity. However, treatment of the same cells with an anti-TL serum and complement 
was  ineffective in  removing suppressor cell activity. Suppression mediated by these 
cells  remained  equal  to  that  of  NMS-treated  cells  (Table  V).  Thus,  the  MLR 
suppressor cells express the Thy-1 +, TL-  surface antigen phenotype. 
Effect  of Adult  Thymectomy  on the Appearance  of MLR Suppressor  Cells  after  TLI.  The 
effect of adult  thymectomy before TLI  on  the subsequent  appearance of the MLR 
suppressor cells was also investigated. BALB/c mice were thymectomized as previously 
described, and 5-6 mo later, one half of the group of thymectomized animals received 
TLI  (total  dose,  3,400  rad).  At  various  times after completion  of TLI,  spleen cells 
obtained  from  mice  in  both  the nonirradiated,  thymectomized  group  and  the  thy- 
mectomized group  given TLI were assayed for suppressor cell activity in the MLR. 
Cells  from  normal  (nonirradiated)  BALB/c  mice  served  as  additional  coculture 
control cells. 
As shown  in Table VI, cells obtained from thymectomized TLI-treated animals  7 
d  after completion of TLI markedly suppressed  (73%)  the MLR.  In most  cases, the 
addition of cells from either normal or adult thymectomized, nonirradiated mice did 
not  affect  the  magnitude  of the  normal  two-party MLR,  although  the  addition of 
cells from  thymectomized  animals occasionally resulted  in a  slight reduction  of the 
response as compared with the addition of cells from normal  (untreated)  mice (data 
not  shown).  In  assessing suppressor activity, comparisons  were  made  between  cells 
from thymectomized, nonirradiated, and thymectomized, TLI-treated animals. 
The pattern of persistence of the suppressor cell after TLI was  also monitored in 
these  experiments,  using cells obtained  from  irradiated mice at  various  times after 
completion  of TLI.  Thymectomy  before  TLI  appeared  to  have  no  effect  on  the 
previously demonstrated pattern of persistence of the suppressor cells (3). Suppressor 
activity gradually decreased with increasing time between irradiation and suppressor 
TABLE  V 
Effect of Treatment with Anti-TL Antibodies and Complement on Suppressor Cells of the MLR 
Source of  Source of  Source of  Percent 
responder  stimulator  eocultured  Treatment ofcocultured cell  Mean [3H]TdR  suppres- 
cell  cell*  eell~  incorporation  sion 
BALB/c  C57BL 
BALB/c  C57BL 
BALB/c  C57BL 
BALB/c  C57BL 
BALB/c  C57BL 
BALB/c  C57BL 
BALB/c  C57BL 
BALB/c  C57BL 
gp?B 
/Ka  BALB/c  1:5 NMS + C'§  32,241 _  1,071  -- 
/Ka  TLI  1:5 NMS + C'  5,503 + 659  83 
/Ka  TLI  1:5 anti-Thy-l.2 + C'  22,829 ± 971  29 
/Ka  TLI  1:5 anti-TL + C'  7,893 +  798  76 
/Ka  BALB/c  1:5 NMS + C'  21,129 + 3,748  -- 
/Ka  TLI  1:5 NMS + C'  6,582 + 810  69 
/Ka  TLI  1:5 anti-Thy-l.2 + C'  18,443 ±  1,275  13 
/Ka  TLI  1:5 anti-TL + C'  7,688 ±  1,148  64 
* 3,400 rad in vitro. 
:]: 1,500 rad in vitro. 
§ C', complement. 
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TABLE  VI 
Effect of Adult Thymectomy on the Appearance of the Suppressor Cell after TLI 
Days after  Source of re-  Source of stimula-  Source of cocul-  Mean [aH]TdR  Percent 
TLI  sponder cells  tor cells*  tured cells:~  incorporation  suppression 
cp?// 
7  BALB/c  BALB/c  BALB/e  1,243 ±  27 
BALB/c  C57BL/Ka  Tx§  35,729 +  2,641 
BALB/c  C57BL/Ka  Tx + TLI§  9,684 +  464  73 
14  BALB/c  BALB/c  BALB/c  2,397 +  254 
BALB/c  C57BL/Ka  Tx  61,878 +  2,964 
BALB/c  C57BL/Ka  Tx + TLI  25,898 ±  701  58 
21  BALB/c  BALB/c  BALB/c  291 ±  51 
BALB/c  C57BL/Ka  Tx  17,025 ±  750 
BALB/c  C57BL/Ka  Tx +  TLI  7,404 ±  1,721  57 
35  BALB/c  BALB/c  BALB/c  1,228 +  62 
BALB/c  C57BL/Ka  Tx  60,863 ±  1,861 
BALB/c  C57BL/Ka  Tx + TLI  36,389 ±  1,557  40 
45  BALB/c  BALB/c  BALB/c  444 ±  231 
BALB/c  C57BL/Ka  Tx  23,470 ±  1,257 
BALB/c  C57BL/Ka  Tx + TLI  19,097 ±  1,243  19 
55  BALB/c  BALB/c  BALB/c  1,196 ±  76 
BALB/c  C57BL/Ka  Tx  16,930 ±  1,237 
BALB/c  C57BL/Ka  Tx + TLI  18,032 ±  1,143  -- 
* 3,400.tad in vitro. 
:l: 1,500 rad in vitro. 
§ Tx, cells obtained  from  thymectomized  BALB/c  mice;  Tx +  TLI, cells obtained  from  thymectomized 
BALB/c mice given TLI. 
One of two experiments at each time-point  is shown. 
cell assay (Table VI). By 55 d after TLI, no suppressor activity could be demonstrated 
using spleen cells from TLI-treated animals  (Table VI). Throughout this time course, 
the responses of both BALB/c and C57BL/Ka responder cells were equally suppressed 
(data not shown). 
Discussion 
Our  previous  studies  have  shown  that  the  spleens  of BALB/c  mice  given  TLI 
contain suppressor cells of the adoptive anti-DNP antibody response and of the MLR 
(2,  3).  Recently, we described  a  large subpopulation of TL + cells  in the spleen  and 
lymph  nodes  of  similarly  treated  mice. 2  The  object  of  the  present  study  was  to 
determine whether the suppressor cells express the TL antigen on their cell surface. 
To study the suppression of humoral immune responses by spleen cells from TLI- 
treated mice, irradiated  (500 rad) BALB/c mice were given limiting numbers of BSA- 
primed T  cells, an excess of DNP-primed  B cells, and an intraperitoneal injection of 
DNP-BSA  in saline.  Co-transfer  of 25  ×  106  spleen  cells  from  TLI-treated  donors 
reduced adoptive secondary responses >80%, as compared with that observed with 25 
×  106 cells from animals given a single dose of sublethal (550 rad) WBI. Because the 
TLI-treated  donors  had  not  received  any  stimulating  antigen  before  cell  transfer, 
inhibition of the adoptive response was considered non-antigen-specific.  Suppressive 
activity  was  dependent  upon  T  cells  that  bear  the  TL  surface  antigen,  because 
treatment of the spleen cells with anti-Thy-1.2 or anti-TL antiserum and complement 
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after  completion  of TLI.  However,  no  suppressor  cells  developed  in  adult  mice 
thymectomized before the administration of radiotherapy. 
Although the suppressor cells of the MLR in TLI-treated mice were removed after 
incubation with anti-Thy-l.2 antibodies and complement (see also ref. 3), these cells 
appear to differ from those that suppress the adoptive anti-DNP response. The activity 
of the MLR suppressors was neither eliminated by treatment with anti-TL serum and 
complement, nor by adult  thymectomy before TLI. In addition,  previous work has 
shown that these suppressor cells are detectable for only 30-40 d  after completion of 
irradiation  (3).  These  studies  indicate  that  at  least  two  distinct  suppressor  T  cell 
populations  that  differ  both  in  their  cell  surface  antigen  phenotype  and  in  their 
functional capabilities are present in the peripheral lymphoid tissues after TLI (Table 
VII). 
Nonspecific suppressor T  cells of humoral antibody responses in young mice have 
been reported previously by Mosier and Johnson  (8).  These in  vitro studies  shown 
that an excess of suppressor T  cells in the neonatal spleen cell population inhibits the 
response of the  functionally  mature  neonatal  B  cells.  Other  investigators  (9)  have 
shown that nylon wool nonadherent  spleen cells of 1-wk-old animals nonspecifically 
suppress  both  the  primary and  secondary  plaque-forming  cell  responses  to  sheep 
erythrocytes in vitro. 
Recently,  Mosier et  al.  (10)  examined  the phenotype of the  neonatal  suppressor 
cells  found  in  the  thymus.  Suppressors of the  antibody response are large,  rapidly 
dividing cells located  in  the outer cortex. These cells constitute a  minor proportion 
(<5%)  of the total T  cell population  within  the thymus, and  have an  Lyt-1 +,  Lyt- 
2,3 ÷, TL  + surface antigen phenotype. Although the spleen cells with similar suppressor 
activity were contained  in  a  fraction of cells too small to permit  direct  phenotypic 
analysis, the authors inferred from their data that the splenic and thymic suppressor 
cells had  the  identical  phenotype  (10).  These neonatal  cells are similar to the TL  + 
suppressor cells found  in TLI-treated mice, although  the  Lyt antigen  phenotype of 
the latter cells has not yet been established. 
Nonspecific suppressor cells of the MLR have also been reported previously in the 
spleens ofaduh animals. Folch and Waksman (11) described the presence of a weakly, 
glass-adherent,  thymus-dependent  suppressor  cell  of  the  MLR  in  the  spleens  of 
unimmunized  adult  rats.  Removal of this cell population  resulted  in an increase in 
TABLE  VII 
Characteristics of Suppressor Cells Found in Mice after TLI 
Suppressor cells of 
Adoptive  anti-DNP 
response  MLR 
* Not done. 
Persist more than 30 d after TLI  +  - 
Cells found in spleen  +  + 
Cells found in lymph node  +  - 
Radiosensitive (~1,500 rad)  ND*  - 
Surface markers: Thy- 1.2  +  + 
TL  +  - 
Susceptible to adult thymectomy  +  - 22  TOTAL  LYMPHOID IRRADIATION-INDUCED SUPPRESSOR T  CELLS 
the MLR response of the remaining cells.  Similarly, a  nylon wool column-adherent 
subpopulation  of splenic  murine  T  cells  has been  isolated  after in  vitro culture  of 
spleen cells without  antigen  for 3-7  d  (12,  13).  These cultured  cells nonspecifically 
suppress the MLR and the in vitro induction of cell-mediated cytotoxicity (13). 
The unexpected finding that two distinct suppressor T  cell subpopulations appear 
to regulate different aspects of immune responsiveness in TLI-treated mice adds an 
additional level of complexity to the analysis of the cellular mechanisms that underlie 
the unusual effects of TLI on the immune system. The role of these suppressor cells in 
the induction of tolerance to heterologous proteins or transplantation antigens in TLI- 
treated mice (2,  14) is not clear. It is possible that the TL  + nonspecific suppressor cells 
differentiate into antigen-specific suppressor cells after interaction with heterologous 
proteins  in  solution.  This'notion  is  consistent  with  the  presence of antigen-specific 
suppressor  T  cells  in  the  spleens  of  TLI-treated  mice  tolerized  to  BSA  by  the 
intraperitoneal  injection of the protein in saIine (2). 
However, it is unlikely that the TL- nonspecific suppressors of the MLR differen- 
tiate  into  antigen-specific  suppressors  that  mediate  transplantation  tolerance  after 
stimulation  with alloantigens.  Our recent data suggest that the non-antigen-specific 
MLR  suppressors  facilitate  tolerance  induction  in  allogeneic  BM  chimeras  by the 
preferential  inhibition  of the  generation  of cytolytic  T  cells  from  cytolytic  T  cell 
precursors.  However, the nonspecific suppressors do not  inhibit  the  generation of a 
new population of antigen-specific suppressor cells that appear to maintain tolerance 
in  the chimeras  (D.  P.  King and  S.  Strober,  manuscript  in  preparation).  Thus, the 
two  subpopulations  of suppressor  cells  in  TLI-treated  mice  may  not  only  act  on 
different target cell populations, but may also function through different mechanisms 
of regulator-effector cell interactions. 
Summary 
BALB/c mice treated with total lymphoid irradiation  (TLI) develop non-antigen- 
specific suppressor cells of the adoptive secondary antibody response and of the mixed 
leukocyte rea~ztion;  Suppressors of the adoptive anti-DNP  response were eliminated 
by incubation  of spleen cells with anti-Thy-l.2 or anti-thymus-leukemia (TL)  anti- 
serum and complement before cell transfer. Thymectomy before TLI prevented the 
appearance of the latter suppressor cells. On the other hand, suppressors of the MLR 
were  eliminated  by  incubation  of spleen  cells  with  anti-Thy-l.2  but  not  anti-TL 
antiserum  and  complement.  Thymectomy before TLI did  not  prevent  their subse- 
quent development. Thus, two subpopulations of suppressor T  cells that differ in the 
expression of the TL surface antigen, dependence on the presence of the thymus, and 
in regulatory functions develop after TLI. The TL  +, thymus-dependent cell suppresses 
the adoptive antibody response, and the TL-, thymus-independent cell suppresses the 
MLR. 
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